Institutional investors hold a majority ownership of AGN through the 90.26% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended December 2013, these large investors purchased a net $7.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BOSTON TRUST & INVESTMENT MANAGE... Bought 137.6 Thousand shares of Allergan Inc
STRATEGIC ADVISERS, INC. Bought 39.0 Thousand shares of Allergan Inc
SIVIK GLOBAL HEALTHCARE LLC Bought 11.8 Thousand shares of Allergan Inc